Elutia Inc (ELUT)
Elutia Inc. (NASDAQ-ELUT) is a healthcare biotechnology company with common stock listed on the NASDAQ exchange. The security is a common equity instrument, meaning it represents an ownership interest in the company rather than a fund or debt product. Elutia focuses on biologic materials and related medical products used in surgical reconstruction and repair, with activity tied to soft tissue, cardiovascular, and other hospital-based applications. Its business is centered on developed and developing offerings for use in clinical settings. As a listed common stock, ELUT reflects exposure to the company’s operating results and broader biotechnology market conditions.
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NASDAQ-ELUT
|
$1.04
|
7.9% Upside
|
Fair
|
$5
|
420.8% Upside
|
Bargain
|
Fair
|
—
|
—
|
—
|
0.0%
|
August 12, 2026
|
-1.9x
|
1.9x
|
3.4x
|
41.118 M
|
18.171 M
|
9.3%
|
58.9%
|
-4.4
|
—
|
209.4%
|
